ANAVEX New Website - Untitled Page.png

About ANAVEX

Anavex Life Sciences Corp. (Nasdaq: AVXL) is a person-focused, biopharmaceutical company dedicated to therapeutic discovery and development of targeted CNS treatments.

Our Values

Precision Therapeutics

Brain Mono.png

Community-based Insights

Community v3 Mono.png

Scientific Innovation

Innovation v3 Mono.png

Inclusion & Equitable Access

Inclusion v3 Mono.png

Our Team

Management

Christopher U. Missling, PhD, MS, MBA

Walter E Kaufmann, MD

Stephan Toutain, MS, MBA

Edward Hammond, PhD, MD

Emmanuel O Fadiran, RPh, MS, PhD

Daniel Klamer, PhD, MS, MBA

Adebayo Laniyonu, PhD

Directors

Christopher U. Missling, PhD, MS, MBA

Claus van der Velden, PhD

Peter Donhauser, DO

Steffen Thomas, PhD

Scientific Advisors

Jeffrey Cummings, MD

Norman Relkin, MD, PhD

Daniel Weintraub, MD

Andrew J. Cole, MD, FRCP(C)

John Harrison, PhD

Dag Aarsland, MD, PhD

Jacqueline French, MD, FAAN

Corinne Lasmézas, PhD, DVM

Ottavio Arancio, MD, PhD

Tangui Nicolas Maurice, PhD